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S U M M A R Y
Tuberculosis remains a global disease burden, counting more than 9 million new cases per year.
Tuberculosis is caused by infection with Mycobacterium tuberculosis-complex. Though most commonly
affecting the lungs, any organ can become a site of tuberculous infection. Cutaneous tuberculosis is rare,
representing 1-2% of all cases of tuberculosis. There are numerous different cutaneous manifestations of
tuberculosis. We describe two cases of erythema induratum of Bazin, a so-called tuberculid
manifestation of cutaneous TB. Both cases are patients from endemic areas. In the cases presented,
there were no signs of other organs affected, and cutaneous lesions disappeared during anti-tuberculous
treatment.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Since the late 80s, industrialized countries have experienced an
increasing incidence of tuberculosis (TB), mainly due to immigra-
tion. This has led to new health challenges. Even though the
notiﬁcation rates of overall TB and pulmonary TB have been
decreasing in the European Union/European Economic Area since
2002, the proportion of extrapulmonary TB has increased from
16.4% in 2002 to 22.4% in 2011.1
Cutaneous manifestations of TB are rare, and represents 1-2% of
all TB-cases.2 We describe two cases of erythema induratum of
Bazin (EIB), a rare cutaneous manifestation of TB, in immigrants
from endemic areas, presented with no or few symptoms of active
TB.
2. Case presentation
2.1. Case #1
An Afghan male, age 45, was referred for dermatological
evaluation due to round, tender, erythematous skin lesions on both
lower extremities, sized 1-3 cm in diameter. The patient had ﬂed
from Afghanistan over Pakistan to Denmark one year prior to initial
evaluation. He was reported previously healthy and without any
medication. The skin lesions had been present for some months.
The patient reported no night sweats, no weight loss and no
pulmonary symptoms.
A punch skin biopsy was performed, and standard histology
showed lobar panniculitis with focal non-caseous necrosis,http://dx.doi.org/10.1016/j.ijid.2015.08.002
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).vasculitis and granulomas (Figure 1A-D). No acid-fast bacilli were
demonstrated. The patient was found to have a strong positive
Interferon Gamma Release Assay (IGRA)-reaction (Quanti-
FERON1-TB Gold, Cellestis, Ltd., Carnegie, Australia) for
M. tuberculosis infection. Chest x-ray was normal, and the patient’s
blood samples were without suspicious ﬁndings. The patient was
tested negative for HIV and chronic viral hepatitis B and C. Due to
the absence of pulmonary symptoms, the positive IGRA was
interpreted as a manifestation of latent TB, and the patient
underwent six months of mono-therapy with isoniazid and
pyridoxine. The skin eruptions were still present at the end of
treatment.
The patient was re-evaluated one year after end of treatment.
He had increasing dyspnoea, but no expectoration. He had
persistent and new onset of skin eruptions, and a repeated skin
biopsy showed lobar panniculitis. The IGRA was still positive, and
the skin biopsy was polymerase chain reaction (PCR)-negative for M.
tuberculosis-complex. A positron-emission-tomography-CT (PET-CT)
scan revealed one FDG-positive lymph node in the right lung.
Biopsy from this lymph node showed numerous lymphocytes, but
no acid-fast bacilli or malignant cells. PCR was negative for M.
tuberculosis-complex. Due to positive IGRA and the histological
changes found in the punch skin biopsy, skin lesions were
interpreted as erythema induratum of Bazin (EIB). The patient
underwent 8 weeks of treatment with ethambutol, rifampicin,
moxiﬂoxacin and pyrazinamide, followed by 16 weeks of
rifampicin and moxiﬂoxacin. The skin eruptions gradually shrunk,
and had disappeared before end of treatment. Prior to initiation of
treatment, the patient was evaluated for sarcoidosis and asthma byciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
Figure 1. Histopathological ﬁndings of erythema induratum of Bazin.
A, Punch biopsy of the skin. B, There is vasculitis, focally granulomatous. C, Deep dermal and subcutaneous inﬂammation with a dense diffuse neutrophilic and granulomatous
inﬁltrate. D, Widespread leukocytoclasia and necrosis without caseation. (hematoxylin-eosin, original magniﬁcations x 30 (A), x 300 (B and C) and x 500 (D).
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Figure 2. Macroscopic skin changes that are found in erythema induratum of Bazin.
Tender, round, erythematous (approx. 3 cm in size) lesion localized to the calf.
Please note that the photo provided is not from the cases described above, but
lesions from the cases were similar.
Photo courtesy to professor Niels K. Veien, Danderm.
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The dyspnoea disappeared during treatment.
2.2. Case #2
A 67-year old woman from Romania was referred to
dermatological evaluation for tender, round skin-eruptions,
primary located on the trunk and lower extremities. The patient
had been living in Denmark for the last 30 years, and had no known
exposure to TB.
The skin eruptions had been present on/off for the last
25 years, with spontaneous regression some months after
presence. Punch skin biopsy revealed non-caseous necrotising
panniculitis, with no demonstrated acid-fast bacilli. PCR-assay of
the skin biopsy was negative for M. tuberculosis-complex. The
patient had a strong positive IGRA-reaction. Other blood samples
were within reference intervals, and a chest x-ray was normal.
The patient was tested negative for HIV and chronic viral
hepatitis B and C. The clinical and histologic picture was
consistent with EIB.
The patient underwent anti-tuberculous treatment, and the
skin lesions shrunk in size. After six months of treatment, a few
smaller and painless lesions were still present, and treatment
was continued for another three months with acceptable
response.
3. Discussion
Cutaneous TB is classiﬁed into multibacillary and paucibacil-
lary forms.2 Multibacillary forms demonstrate acid-fast bacilli in
biopsies, and include tuberculous chancres, scrofuloderma and
perioriﬁcial TB. Paucibacillary forms include TB- verrucosa cutis,
lupus vulgaris and tuberculids, and are characterized by the
possible absence of acid-fast bacilli. Tuberculids include papu-
lonecrotic tuberculid, lichen scrofulosorum and erythema indur-
atum of Bazin (EIB). Although rare in Western countries, EIB is the
most common of the tuberculids. EIB shows female predomi-
nance, and the cutaneous lesions often occur on the lower
extremities. The lesions are described as tender, erythematous
and may vary from 1 to 5 cm in size. The skin lesions may ulcerate,
and can in these cases cause permanent scarring and/or
hyperpigmentation (Figure 2 – please note that the photo
provided is not from the cases described above, but lesions from
the cases were similar).
EIB is caused by infection with M. tuberculosis-complex. The
direct cause of the skin lesions is unknown, but is thought to be
caused by autoimmune reaction to the presence of the acid-fast
bacilli. EIB shows similarities to nodular vasculitis, which can be
caused by sarcoidosis, chronic hepatitis C and other chronic
inﬂammatory conditions. Both conditions represent a hypersensi-
tivity reaction to antigens, e.g. tubercle bacilli. Positive IGRA can
support infection with M. tuberculosis-complex, and is thus useful
in differentiation between EIB and other causes of nodular
vasculitis.3
Case 1 was re-evaluated due to increasing dyspnoea after six
months of mono-therapy with isoniazid. Since he showed no
expectoration, weight loss or night sweats, and no signs of
inﬁltration by PET-CT, pulmonary TB was not suspected. Since
EIB is regarded as an autoimmune reaction, a possible
explanation for the dyspnoea is a component of pulmonary
vasculitis.
Histologic ﬁndings of EIB are non-speciﬁc, and include mixed
septal and lobular panniculitis with varying combinations of
vasculitis, septal ﬁbrosis, granulomatous inﬂammation and
necrosis, which may be caseation-like (Figure 1A-D).4Treatment of EIB does not differ from conventional antituber-
culous therapy. In the ﬁrst case described here, moxiﬂoxacin was
included, since the patient previously underwent six months of
isoniazid therapy for suspected latent TB, resulting in possible
isoniazid resistance. Skin lesions may be treated with potassium
iodide, but evidence of efﬁcacy is sparse.5
We have described two cases of EIB in patients with no
obvious symptoms of active TB, who were born in TB-endemic
countries, where IGRA has limited clinical relevance in active TB.
Still IGRA was in these cases useful in strengthening a clinical
suspicion of EIB. However, the conﬁrmation of the diagnosis
lay somewhat in the favourable treatment outcome in both
cases.
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